<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-NAFQG7MU</identifier><date>1997</date><creator>Benulič, Tomaž</creator><relation>documents/doc/N/URN_NBN_SI_doc-NAFQG7MU_001.pdf</relation><relation>documents/doc/N/URN_NBN_SI_doc-NAFQG7MU_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 75-83</format><identifier identifier_type="COBISSID_HOST">7721689</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-NAFQG7MU</identifier><language>slv</language><publisher>Glaxo Wellcome</publisher><source>Onkološki vikend</source><rights>BY-NC-ND</rights><subject language_type_id="eng">Brachytherapy</subject><subject language_type_id="eng">Colorectal neoplasms</subject><subject language_type_id="slv">Combine modality therapy</subject><subject language_type_id="eng">Radiotherapy</subject><title>Obsevanje raka širokega črevesa in danke</title></Record>